FDA grants reprocessors SUDS liberties
This article was originally published in Clinica
Executive Summary
The US FDA says it may give reprocessors of devices intended for single use (SUDS) the option to relabel products "multiple use" if the reprocessors can provide sufficient scientific evidence that the product can be safely reused.